Subviral hepatitis B virus filaments, like infectious viral particles, are released via multivesicular bodies

Journal of Virology

Volumn 90, Issue 7, 2016, Pages 3330-3341

  Jiang, Bingfu ^a   Himmelsbach, Kiyoshi ^a   Ren, Huimei ^a   Boller, Klaus ^a   Hildt, Eberhard ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ESCRT PROTEIN; 3-BETA-(2-(DIETHYLAMINO)ETHOXY)ANDROST-5-EN-17-ONE; ANDROSTANE DERIVATIVE; CORE PROTEIN; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUSCEPTIBILITY GENE 101 PROTEIN; TXLNA PROTEIN, HUMAN; VESICULAR TRANSPORT PROTEIN;

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; GENE EXPRESSION; GENOME ANALYSIS; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOELECTRON MICROSCOPY; MULTIVESICULAR BODY; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS GENOME; VIRUS MORPHOGENESIS; VIRUS PARTICLE; VIRUS RELEASE; ANTAGONISTS AND INHIBITORS; CYTOSKELETON; DEFICIENCY; DRUG EFFECTS; ELECTRON MICROSCOPY; GENETICS; HEP-G2 CELL LINE; LIVER CELL; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE; VIROLOGY;

ANDROSTENES; CELL LINE, TUMOR; CYTOSKELETON; DNA-BINDING PROTEINS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; HEP G2 CELLS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON; MULTIVESICULAR BODIES; TRANSCRIPTION FACTORS; VESICULAR TRANSPORT PROTEINS; VIRAL CORE PROTEINS; VIRUS RELEASE;

EID: 84960971044     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03109-15     Document Type: Article

References (56)

1. Schadler S, Hildt E. 2009. HBV life cycle: entry and morphogenesis. Viruses 1:185-209. http://dx.doi.org/10.3390/v1020185.
2. Gerlich WH, Heermann KH, Lu X. 1992. Functions of hepatitis B surface proteins. Arch Virol Suppl 4:129-132. http://dx.doi.org/10.1007/978-3-7091-5633-9_28.
3. Heermann KH, Goldmann U, Schwartz W, Seyffarth T, Baumgarten H, Gerlich WH. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J Virol 52:396-402.
4. Bruss V. 2007. Hepatitis B virus morphogenesis. World J Gastroenterol 13:65-73. http://dx.doi.org/10.3748/wjg.v13.i1.65.
5. Garcia T, Li J, Sureau C, Ito K, Qin Y, Wands J, Tong S. 2009. Drastic reduction in the production of subviral particles does not impair hepatitis B virus virion secretion. J Virol 83:11152-11165. http://dx.doi.org/10.1128/JVI.00905-09.
6. Peiffer KH, Akhras S, Himmelsbach K, Hassemer M, Finkernagel M, Carra G, Nuebling M, Chudy M, Niekamp H, Glebe D, Sarrazin C, Zeuzem S, Hildt E. 2014. Intracellular accumulation of subviral HBsAg particles and diminished Nrf2 activation in HBV genotype G expressing cells lead to an increased ROI level. J Hepatol 62:791-798. http://dx.doi.org/10.1016/j.jhep.2014.11.028.
7. Bruns M, Miska S, Chassot S, Will H. 1998. Enhancement of hepatitis B virus infection by noninfectious subviral particles. J Virol 72:1462-1468.
8. Patient R, Hourioux C, Roingeard P. 2009. Morphogenesis of hepatitis B virus and its subviral envelope particles. Cell Microbiol 11:1561-1570. http://dx.doi.org/10.1111/j.1462-5822.2009.01363.x.
9. Patient R, Hourioux C, Sizaret PY, Trassard S, Sureau C, Roingeard P. 2007. Hepatitis B virus subviral envelope particle morphogenesis and intracellular trafficking. J Virol 81:3842-3851. http://dx.doi.org/10.1128/JVI.02741-06.
10. Watanabe T, Sorensen EM, Naito A, Schott M, Kim S, Ahlquist P. 2007. Involvement of host cellular multivesicular body functions in hepatitis B virus budding. Proc Natl Acad Sci U S A 104:10205-10210. http://dx.doi.org/10.1073/pnas.0704000104.
11. Lambert C, Doring T, Prange R. 2007. Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol 81:9050-9060. http://dx.doi.org/10.1128/JVI.00479-07.
12. Votteler J, Sundquist WI. 2013. Virus udding and the ESCRT pathway. Cell Host Microbe 14:232-241. http://dx.doi.org/10.1016/j.chom.2013.08.012.
13. Martin-Serrano J, Yarovoy A, Perez-Caballero D, Bieniasz PD. 2003. Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins. Proc Natl Acad Sci U S A 100:12414-12419. http://dx.doi.org/10.1073/pnas.2133846100.
14. Strack B, Calistri A, Craig S, Popova E, Gottlinger HG. 2003. AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 114:689-699. http://dx.doi.org/10.1016/S0092-8674(03)00653-6.
15. Carlson LA, Hurley JH. 2012. In vitro reconstitution of the ordered assembly of the endosomal sorting complex required for transport at membrane-bound HIV-1 Gag clusters. Proc Natl Acad Sci U S A 109: 16928-16933. http://dx.doi.org/10.1073/pnas.1211759109.
16. Bishop N, Woodman P. 2000. ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking. Mol Biol Cell 11:227-239. http://dx.doi.org/10.1091/mbc.11.1.227.
17. Fujita H, Yamanaka M, Imamura K, Tanaka Y, Nara A, Yoshimori T, Yokota S, Himeno M. 2003. A dominant negative form of the AAA ATPase SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal compartments: class E vps phenotype in mammalian cells. J Cell Sci 116:401-414. http://dx.doi.org/10.1242/jcs.00213.
18. Rost M, Mann S, Lambert C, Doring T, Thome N, Prange R. 2006. Gamma-adaptin, a novel ubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase control hepatitis B virus maturation. J Biol Chem 281:29297-29308. http://dx.doi.org/10.1074/jbc. M603517200.
19. Hoffmann J, Boehm C, Himmelsbach K, Donnerhak C, Roettger H, Weiss TS, Ploen D, Hildt E. 2013. Identification of alpha-taxilin as an essential factor for the life cycle of hepatitis B virus. J Hepatol 59:934-941. http://dx.doi.org/10.1016/j.jhep.2013.06.020.
20. Roingeard P. 2003. Vacuolization in hepatitis B virus-infected hepatocytes. Hepatology 37:1223-1224. http://dx.doi.org/10.1053/jhep.2003.50168.
21. Roingeard P, Sureau C. 1998. Ultrastructural analysis of hepatitis B virus in HepG2-transfected cells with special emphasis on subviral filament morphogenesis. Hepatology 28:1128-1133. http://dx.doi.org/10.1002/hep.510280431.
22. Ehrhardt C, Schmolke M, Matzke A, Knoblauch A, Will C, Wixler V, Ludwig S. 2006. Polyethylenimine, a cost-effective transfection reagent. Signal Transduction 6:179-184. http://dx.doi.org/10.1002/sita.200500073.
23. Kucinskaite-Kodze I, Pleckaityte M, Bremer CM, Seiz PL, Zilnyte M, Bulavaite A, Mickiene G, Zvirblis G, Sasnauskas K, Glebe D, Zvirbliene A. 2015. New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen. Virus Res 211:209-221. http://dx.doi.org/10.1016/j.virusres.2015.10.024.
24. Dahl NK, Reed KL, Daunais MA, Faust JR, Liscum L. 1992. Isolation and characterization of Chinese hamster ovary cells defective in the intracellular metabolism of low density lipoprotein-derived cholesterol. J Biol Chem 267:4889-4896.
25. Higgins ME, Davies JP, Chen FW, Ioannou YA. 1999. Niemann-Pick C1 is a late endosome-resident protein that transiently associates with lysosomes and the trans-Golgi network. Mol Genet Metab 68:1-13. http://dx.doi.org/10.1006/mgme.1999.2882.
26. Kobayashi T, Beuchat MH, Chevallier J, Makino A, Mayran N, Escola JM, Lebrand C, Cosson P, Kobayashi T, Gruenberg J. 2002. Separation and characterization of late endosomal membrane domains. J Biol Chem 277:32157-32164. http://dx.doi.org/10.1074/jbc. M202838200.
27. Chudy M, Hanschmann KM, Kress J, Nick S, Campos R, Wend U, Gerlich W, Nubling CM. 2012. First WHO International Reference Panel containing hepatitis B virus genotypes A-G for assays of the viral DNA. J Clin Virol 55:303-309. http://dx.doi.org/10.1016/j.jcv.2012.08.013.
28. Huber LA, Pfaller K, Vietor I. 2003. Organelle proteomics: implications for subcellular fractionation in proteomics. Circ Res 92:962-968. http://dx.doi.org/10.1161/01.RES.0000071748.48338.25.
29. Burckstummer T, Kriegs M, Lupberger J, Pauli EK, Schmittel S, Hildt E. 2006. Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication. FEBS Lett 580:575-580. http://dx.doi.org/10.1016/j.febslet.2005.12.071.
30. Brandenburg B, Stockl L, Gutzeit C, Roos M, Lupberger J, Schwartlander R, Gelderblom H, Sauer IM, Hofschneider PH, Hildt E. 2005. A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle. Hepatology 42:1300-1309. http://dx.doi.org/10.1002/hep.20950.
31. Chai N, Chang HE, Nicolas E, Han Z, Jarnik M, Taylor J. 2008. Properties of subviral particles of hepatitis B virus. J Virol 82:7812-7817. http://dx.doi.org/10.1128/JVI.00561-08.
32. Hayat FM. 1970. Principles and techniques of electron microscopy: biological applications. Cambridge University Press, Cambridge, United Kingdom.
33. Lupberger J, Schaedler S, Peiran A, Hildt E. 2013. Identification and characterization of a novel bipartite nuclear localization signal in the hepatitis B virus polymerase. World J Gastroenterol 19:8000-8010. http://dx.doi.org/10.3748/wjg.v19.i44.8000.
34. Chavrier P, Parton RG, Hauri HP, Simons K, Zerial M. 1990. Localization of low molecular weight GTP binding proteins to exocytic and endocytic compartments. Cell 62:317-329. http://dx.doi.org/10.1016/0092-8674(90)90369-P.
35. Vanlandingham PA, Ceresa BP. 2009. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem 284:12110-12124. http://dx.doi.org/10.1074/jbc. M809277200.
36. Feng Y, Press B, Wandinger-Ness A. 1995. Rab 7: an important regulator of late endocytic membrane traffic. J Cell Biol 131:1435-1452. http://dx.doi.org/10.1083/jcb.131.6.1435.
37. Roth J, Berger EG. 1982. Immunocytochemical localization of galactosyltransferase in HeLa cells: codistribution with thiamine pyrophosphatase in trans-Golgi cisternae. J Cell Biol 93:223-229. http://dx.doi.org/10.1083/jcb.93.1.223.
38. Lucocq JM, Berger EG, Warren G. 1989. Mitotic Golgi fragments in HeLa cells and their role in the reassembly pathway. J Cell Biol 109:463-474. http://dx.doi.org/10.1083/jcb.109.2.463.
39. Fialka I, Pasquali C, Lottspeich F, Ahorn H, Huber LA. 1997. Subcellular fractionation of polarized epithelial cells and identification of organelle-specific proteins by two-dimensional gel electrophoresis. Electrophoresis 18:2582-2590. http://dx.doi.org/10.1002/elps.1150181414.
40. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, Myszka DG, Sundquist WI. 2001. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 107:55-65. http://dx.doi.org/10.1016/S0092-8674(01)00506-2.
41. Huovila AP, Eder AM, Fuller SD. 1992. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 118:1305-1320. http://dx.doi.org/10.1083/jcb.118.6.1305.
42. Stieler JT, Prange R. 2014. Involvement of ESCRT-II in hepatitis B virus morphogenesis. PLoS One 9:e91279. http://dx.doi.org/10.1371/journal.pone.0091279.
43. Chisari FV, Klopchin K, Moriyama T, Pasquinelli C, Dunsford HA, Sell S, Pinkert CA, Brinster RL, Palmiter RD. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59:1145-1156. http://dx.doi.org/10.1016/0092-8674(89)90770-8.
44. Chisari FV, Filippi P, Buras J, McLachlan A, Popper H, Pinkert CA, Palmiter RD, Brinster RL. 1987. Structural and pathological effects of synthesis of hepatitis B virus large envelope polypeptide in transgenic mice. Proc Natl Acad Sci U S A 84:6909-6913. http://dx.doi.org/10.1073/pnas.84.19.6909.
45. Chisari FV, Filippi P, McLachlan A, Milich DR, Riggs M, Lee S, Palmiter RD, Pinkert CA, Brinster RL. 1986. Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice. J Virol 60:880-887.
46. Standring DN, Ou JH, Rutter WJ. 1986. Assembly of viral particles in Xenopus oocytes: pre-surface antigens regulate secretion of the hepatitis B viral surface envelope particle. Proc Natl Acad Sci U S A 83:9338-9342. http://dx.doi.org/10.1073/pnas.83.24.9338.
47. Hurtley SM, Helenius A. 1989. Protein oligomerization in the endoplasmic reticulum. Annu Rev Cell Biol 5:277-307. http://dx.doi.org/10.1146/annurev.cb.05.110189.001425.
48. Ellgaard L, Molinari M, Helenius A. 1999. Setting the standards: quality control in the secretory pathway. Science 286:1882-1888. http://dx.doi.org/10.1126/science.286.5446.1882.
49. Bayer ME, Blumberg BS, Werner B. 1968. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's syndrome and hepatitis. Nature 218:1057-1059. http://dx.doi.org/10.1038/2181057a0.
50. Sureau C, Romet-Lemonne JL, Mullins JI, Essex M. 1986. Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47:37-47. http://dx.doi.org/10.1016/0092-8674(86)90364-8.
51. Sells MA, Chen ML, Acs G. 1987. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci U S A 84:1005-1009. http://dx.doi.org/10.1073/pnas.84.4.1005.
52. Scheuring S, Rohricht RA, Schoning-Burkhardt B, Beyer A, Muller S, Abts HF, Kohrer K. 2001. Mammalian cells express two VPS4 proteins both of which are involved in intracellular protein trafficking. J Mol Biol 312:469-480. http://dx.doi.org/10.1006/jmbi.2001.4917.
53. von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, Wang HE, Davis T, He GP, Cimbora DM, Scott A, Krausslich HG, Kaplan J, Morham SG, Sundquist WI. 2003. The protein network of HIV budding. Cell 114:701-713. http://dx.doi.org/10.1016/S0092-8674(03)00714-1.
54. Lin Y, Kimpler LA, Naismith TV, Lauer JM, Hanson PI. 2005. Interaction of the mammalian endosomal sorting complex required for transport (ESCRT) III protein hSnf7-1 with itself, membranes, and the AAA+ATPase SKD1. J Biol Chem 280:12799-12809. http://dx.doi.org/10.1074/jbc. M413968200.
55. Bruss V, Lu X, Thomssen R, Gerlich WH. 1994. Posttranslational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J 13:2273-2279.
56. Prange R, Streeck RE. 1995. Novel transmembrane topology of the hepatitis B virus envelope proteins. EMBO J 14:247-256.